Review maps quinazoline inhibitors targeting tubulin polymerisation, suggesting significant progress in drug development.
Over the past two decades, the quinazoline scaffold has emerged as a privileged framework in the development of small molecule tubulin polymerisation inhibitors. Here we map the chemical space of...
No takes yet. Share an insight, caveat, or question.
O'Brien et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: